Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Basilea Pharmaceutica develops antibacterial activity enhancers

Dec. 30, 2016

Hangzhou Innogate Pharma describes SYK/HDAC inhibitors

Dec. 30, 2016

Femtogenix discloses anticancer agents

Dec. 30, 2016

East China University of Science and Technology patents HER1 inhibitors

Dec. 30, 2016

Chiesi Farmaceutici presents muscarinic M3 receptor antagonists and beta2-adrenoceptor agonists

Dec. 29, 2016

Dana-Farber Cancer Institute develops SMO receptor antagonists

Dec. 29, 2016

Syros Pharmaceuticals describes c-Myc inhibitors

Dec. 29, 2016

Medshine Discovery discloses JAK inhibitors

Dec. 29, 2016

Vertex Pharmaceuticals patents triazoles for demyelinating diseases

Dec. 29, 2016

Merck & Co. and MSD R&D disclose PDE2A inhibitors

Dec. 28, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...